IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelZhen Ning Wee, Qiang Yu|Nature Communications|2015Cited by 170
Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal CancerWenyu Wang, Qiang Yu|Nature Communications|2021Cited by 115
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancerSylvia Mahara, Qiang Yu|Proceedings of the National Academy of Sciences|2016Cited by 90
RASAL2 activates RAC1 to promote triple-negative breast cancer progressionMin Feng, Qiang Yu|Journal of Clinical Investigation|2014Cited by 86
Apoptosis Signal-regulating Kinase 1 Is a Direct Target of E2F1 and Contributes to Histone Deacetylase Inhibitorinduced Apoptosis through Positive Feedback Regulation of E2F1 Apoptotic ActivityJing Tan, Qiang Yu|Journal of Biological Chemistry|2006Cited by 63